Amanote Research

Amanote Research

    RegisterSign In

TET2 Deficiency Sets the Stage for B-Cell Lymphoma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-18-1143
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

December 1, 2018

Authors
Jennifer R. ShingletonSandeep S. Dave
Publisher

American Association for Cancer Research (AACR)


Related search

B-Cell Lymphoma, Thiamine Deficiency, and Lactic Acidosis

Baylor University Medical Center Proceedings
Medicine
2017English

TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation and Promotes B-Cell Lymphomagenesis

Cancer Discovery
Oncology
2018English

Precision Epigenetic Therapy for B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Hematopoietic Cell Transplantation for B-Cell Lymphoma: An Update

Cancer Control
MedicineOncologyHematology
2012English

Peripheral T-Cell Lymphoma Mimicking Marginal Zone B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2002English

Diffuse Large B-Cell Lymphoma

2020English

Intravascular Large B-Cell Lymphoma

2020English

Marginal Zone B-Cell Lymphoma

English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy